Summary: MedBright AI Investments Inc. has formed a partnership with Rejuvenation medical group, a leading dermatology group in Canada, to implement MedMatrix, an AI-powered data analytics platform. With a network of 9 clinics across 3 provinces and a team of highly skilled dermatologists, Mohs surgeons, plastic surgeons, and general practitioners, Rejuvenation medical group is known for its advanced dermatological care. The integration of MedMatrix is expected to enhance their healthcare offerings by optimizing clinic operations and improving patient outcomes.
Under the partnership, MedMatrix will utilize artificial intelligence to evaluate and analyze various aspects of Rejuvenation’s clinics, including patient needs, revenue management, demographics, and competition. By leveraging advanced data analytics, the platform aims to improve clinic operations, enhance the patient experience, and increase clinic revenue.
Dr. Paul Kuzel, Medical Director and Dermatologist at Rejuvenation medical group, expressed excitement about the collaboration, stating that AI technology is crucial in improving the patient experience and clinic revenue. Trevor Vieweg, CEO of MedBright, emphasized that partnering with Rejuvenation medical group is a significant milestone for both companies, as its scale allows for a demonstration of the value and benefits of MedMatrix in clinic operations.
MedBright AI Investments Inc. focuses on investing in healthcare technology companies and aims to generate superior returns for its shareholders. By actively seeking high-quality investment opportunities and prioritizing governance, MedBright aims to construct a portfolio of synergistic investments in the healthcare industry.
This partnership between MedBright AI and Rejuvenation medical group represents a step forward in revolutionizing dermatology care by integrating AI technology into clinic operations, ultimately improving patient care and outcomes.